Goldman Sachs Group assumed coverage on shares of Afya (NASDAQ:AFYA) in a research report report published on Tuesday morning, BenzingaRatingsTable reports. The firm issued a neutral rating and a $26.00 price objective on the stock.

Several other equities research analysts have also recently weighed in on AFYA. Bank of America began coverage on Afya in a report on Tuesday. They issued a buy rating and a $29.00 target price for the company. Morgan Stanley began coverage on Afya in a report on Tuesday. They issued an overweight rating and a $29.20 target price for the company. Finally, JPMorgan Chase & Co. began coverage on Afya in a report on Friday, August 9th. They issued an overweight rating and a $34.00 target price for the company.

Shares of AFYA stock opened at $25.59 on Tuesday. Afya has a twelve month low of $22.00 and a twelve month high of $29.37.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Featured Story: What are no-load funds?

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.